Building on the success of mRNA vaccines for Covid, scientists hope to create mRNA-based vaccines against a host of pathogens, including influenza, Zika, rabies, HIV and respiratory syncytial virus, or RSV, which hospitalizes three million children under age 5 each year worldwide.
